[1] Pappas PC,,Rex JH,Sobel JD,et al.Guidelines for treatment of candidiasis[J].Clin Infect Dis,2004,38(2):161-189. [2] Trofa D,Gacser A,Nosanchuk JD.Candida parapsilosis,an emerging fungal pathogen[J].Clin Microbiol Rev,2008,21(4):606-625. [3] Pfaller MA,Diekema DJ,Jones RN,et al.International surveillance of bloodstream infections due to Candida species:frequency of occurrence and in vitro susceptibilities to fluconazole,ravuconazole,and voriconazole of isolates collected from 1997through 1999 in the SENTRY antimicrobial surveillance program[J].J Clin Microbiol,2001,39(9):3254-3259. [4] Nakamura T,Takahashi H.Epidemiological study of Candida infections in blood:susceptibilities of Candida spp.to antifungal agents,and clinical features associated with the candidemia[J].J Infect Chemother,2006,12(3):132-138. [5] Medrano DJ,Brilhante RS,Cordeiro Rde A,et al.Candidemia in a Brazilian hospital:the importance of Candida parapsilosis[J].Rev Inst Med Trop Sao Paulo,2006,48(1):17-20. [6] Sarvikivi E,Lyytikainen O,Soll DR,et al.Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit[J].J Clin Microbiol,2005,43(6):2729-2735. [7] Pfaller MA,Diekema DJ,Messor SA,et al.Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution,disk diffusion,and Etest methods:report from the ARTEMIS Global Antifungal Susceptibility Program,2001[J].J Clin Microbiol,2003,41 (4):1440-1446. [8] Okhravi N,Adamson P,Mant R,et al.Polymerase chain reaction and restriction fragment length polymorphism mediated detection and speciation of Candida spp.causing intraocular infection[J].Invest Ophthalmol Via Sci,1998,39(6):859-866. [9] Sambrook J,Russell DW.黄培堂等译,分子克隆实验指南[M].第3版.北京:科学出版社,2002:27-99. [10] Marichal P,Koymans L,Willemsens S,et al.Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11 p,Cyp51 p) to azole resistance in Candida albicans[J].Microbiology,1999,145(Pt 10):2701-2713. [11] Sanglard D,Ischer F,Koymans L,et al.Amino acid substitutions in the cytochrome P-450 lanostorol 14alpha-demethylase (CYP51 A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents[J].Antimicrob Agents Chemother,1998,42 (2):241-253. [12] Kakeya H,Miyazaki Y,Miyazaki H,et al.Genetic analysis of azole resistance in the Darlington strain of Candida albicans[J].Antimicrob Agents Chemother,2000,44 (11):2985-2990. [13] Ji H,Zhang W,Zhou Y,et al.A three-dimensional model of lanosterol 14alpha-demethylase of Candida albicans and its interaction with azole antifungals[J].J Med Chem,2000,43(13):2493-2505. |